Provided by Tiger Trade Technology Pte. Ltd.

Vor Biopharma Inc.

14.48
+0.91006.71%
Post-market: 14.45-0.0300-0.21%19:38 EDT
Volume:1.72M
Turnover:24.77M
Market Cap:601.21M
PE:-0.04
High:14.98
Open:13.66
Low:13.64
Close:13.57
52wk High:65.80
52wk Low:2.62
Shares:41.52M
Float Shares:18.97M
Volume Ratio:0.99
T/O Rate:9.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-386.8600
EPS(LYR):-34.0333
ROE:-125.43%
ROA:-144.27%
PB:-0.27
PE(LYR):-0.43

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

Vor Biopharma Shares Rise 1.5% After $75 Million Private Placement

THOMSON REUTERS
·
Mar 27

Vor Biopharma Announces $75 Million Private Placement

MT Newswires Live
·
Mar 27

Vor Biopharma Shares Climb 6.4% Premarket After $75 Million Private Placement

THOMSON REUTERS
·
Mar 27

Vor Bio sells 5,338,078 shares in private placement; gross proceeds rise to $75 million

Reuters
·
Mar 27

BRIEF-Vor Bio Announces $75 Million Private Placement With Tcgx

Reuters
·
Mar 27

Vor Biopharma Inc - Bio to Use Proceeds to Advance Telitacicept Clinical Development

THOMSON REUTERS
·
Mar 27

BRIEF-Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Mar 24

Vor Bio reports inducement grants of 215,700 stock options and 46,235 RSUs under Nasdaq Rule 5635(c)(4)

Reuters
·
Mar 24

Vor Biopharma Inc expected to post a loss of $1.64 a share - Earnings Preview

Reuters
·
Mar 16

RemeGen FY2025 revenue CNY3.3bn up 89.4%

Reuters
·
Feb 27

Vor Biopharma Inc - Prospectus for Resale of 13.9 Mln Shares of Common Stock by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Jan 30

Vor Biopharma Unveils Telitacicept Data Targeting B Cell-Driven Autoimmune Diseases

Reuters
·
Jan 16

Vor Biopharma to Highlight Telitacicept at JPM Conference

TIPRANKS
·
Jan 12

Vor Biopharma Initiated at Buy by Citigroup

Dow Jones
·
Jan 09

Vor Biopharma Inc : Citigroup Initiates Coverage With Buy Rating; Price Target $50

THOMSON REUTERS
·
Jan 09

Vor Bio initiated with a Buy at Citi

TIPRANKS
·
Jan 09

Vor Biopharma Announces Separation Agreement With Chief Development Officer Qing Zuraw

Reuters
·
Jan 03

Getty Images, Torm, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
Jan 03

Vor Biopharma Adds Andrew Levin and Wouter Joustra to Board

Reuters
·
Dec 24, 2025